CHOP-14 protocol
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
The efficiency of upfront consolidation with high‐dose chemotherapy/autologous stem‐cell transplantation (HDCT/ASCT) for newly…
Background:HDT with ASCT (HDT/ASCT) is an option as the upfront consolidation for poor-risk DLBCL. However, its role remains…
ZusammenfassungDas diffuse großzellige B‑Zell-Lymphom („diffuse large B‑cell lymphoma“ –DLBCL) ist das häufigste Non-Hodgkin…
7592 Background: Several studies have shown that the addition of rituximab (R) to CHOP (cyclophosphamide, doxorubicin…
Introduction: Early ASCT improves progression-free survival (PFS) but not overall survival (OS) in poor prognosis DLBCL treated…
ZusammenfassungDer Internationale Prognose-Index (IPI) erlaubt eine prognostische Einteilung von Patienten mit aggressiven…
8064 Background: In a previous pharmacokinetic study we had shown that the concomitant application of R-CHOP-14 does not achieve…
Background: While 6 to 8 cycles of CHOP in combination with rituximab are widely accepted as standard regimen of care for…
ZusammenfassungDer altersadaptierte Internationale Prognoseindex (IPI) erlaubt eine klinisch relevante Einteilung jüngerer…
Biweekly application of rituximab in combination with biweekly CHOP (R-CHOP-14) results in a slow increase of rituximab serum…